LATOYA BUFORD: Open Payments
NPI 1043738909 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 11 payments from 6 companies in 2025. Trend: 2023 $293 · 2024 $1,104 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $158 |
| Lilly USA, LLC | 2 | $45 |
| Novo Nordisk Inc | 2 | $42 |
| Amgen Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $14 |
Products named: BREZTRI, MOUNJARO, OTEZLA, REXULTI, Wegovy, Cologuard Collection Kit.
Industry payments across GA — which companies pay providers there.
